跳至主要内容
临床试验/NCT01425346
NCT01425346已完成不适用

Freedom Meditech ClearPath DS-120 Clinical Study Protocol FM2-002-CTP

Freedom Meditech1 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2011年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
128
试验地点
1
主要终点
Lens fluorescence

研究概览

简要总结

The goal of this study is to measure lens fluorescence in normal subjects at various chronological ages that could serves as a guide to clinicians in determining changes in eye health. A measure of lens fluorescence can be used by clinicians as an indication of degenerative changes occurring in the lens of the eye.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
21 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Persons between the ages of twenty-one (21) and seventy (70). Best efforts shall be made to include as many patients as possible between the ages of thirty-five (35) and sixty (60).
  • Subject must be able to read or understand and give informed consent.
  • Pass the medical health history and comprehensive ophthalmic examination (which is determined by the investigator if the test subject has a normal ophthalmic examination and is in overall good health). Ophthalmic examination includes a clinical evaluation of the subject's eyes and a complete manifest refraction producing a best aided visual acuity of <20/40.

排除标准

  • Subject has had the crystalline lens removed from the study eye or has had the crystalline lens removed and replaced with an intraocular lens (IOL) implant in the left eye.
  • Subject has been clinically diagnosed with cataracts in the study eye.
  • Subject has had a fluorescence angiogram within the last six months.
  • Subject has undergone a treatment using photodynamic drugs within the last year.
  • Subject has Type I or II diabetes or is not deemed healthy from Demographic and Health Questionnaire or the comprehensive eye exam.
  • Subject was fit with contact lens within the last 30 days.
  • Subject has ocular surface (dry eye) disease.
  • Subject is unable to cooperate with or understand clinical instructions.
  • Subject is unable to complete test sequence

结局指标

主要结局

Lens fluorescence

时间窗: Day 1

evaluate the ability of the ClearPath DS-120 instrument to measure the fluorescence and scattering responses of the human crystalline lens in a normal subject population with healthy eyes (as determined by standard comprehensive ophthalmic examination).

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

ClearPath DS-120 Clinical Study Protocol | 临床试验